Lineage, Inc. Common Stock (LINE)vsWeyerhaeuser Company (WY)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
WY
Weyerhaeuser Company
$22.06
+0.32%
REAL ESTATE · Cap: $16.35B
Smart Verdict
WallStSmart Research — data-driven comparison
Weyerhaeuser Company generates 28% more annual revenue ($6.85B vs $5.37B). WY leads profitability with a 6.9% profit margin vs -3.1%. WY earns a higher WallStSmart Score of 57/100 (C).
LINE
Avoid35
out of 100
Grade: F
WY
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-29.2%
Fair Value
$20.97
Current Price
$22.06
$1.09 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 87.1% YoY
Reasonable price relative to book value
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Premium valuation, high expectations priced in
ROE of 5.0% — below average capital efficiency
6.9% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : WY
The strongest argument for WY centers on EPS Growth, Price/Book. PEG of 1.35 suggests the stock is reasonably priced for its growth.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : WY
The primary concerns for WY are P/E Ratio, Return on Equity, Profit Margin.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while WY is a value play — different risk/reward profiles.
WY carries more volatility with a beta of 0.89 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
WY generates stronger free cash flow (260M), providing more financial flexibility.
Bottom Line
WY scores higher overall (57/100 vs 35/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Weyerhaeuser Company
REAL ESTATE · REIT - SPECIALTY · USA
Weyerhaeuser Company is an American timberland company which owns nearly 12,400,000 acres of timberlands in the U.S. and manages an additional 14,000,000 acres timberlands under long-term licenses in Canada. The company also manufactures wood products. Weyerhaeuser is a real estate investment trust.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?